Lyme neuroborreliosis

被引:10
|
作者
Halperin, John J. [1 ,2 ]
机构
[1] Overlook Med Ctr, Dept Neurosci, 99 Beauvoir Ave, Summit, NJ 07901 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
关键词
CXCL13; encephalopathy; Lyme; neuroborreliosis; post treatment Lyme disease symptom; QUALITY-OF-LIFE; UNITED-STATES; DISEASE; DIAGNOSIS; BORRELIA; SYMPTOMS; OUTCOMES; CXCL13;
D O I
10.1097/QCO.0000000000000545
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review To review the recent evidence clarifying the symptomatology and diagnosis of nervous system Lyme disease. Recent findings Two-tier testing combining pairs of ELISAs, using C6 or VlsE assays to replace second tier Western blots, may eliminate confusion about test interpretation. Cerebrospinal fluid (CSF) can be informative in diagnosing central nervous system (CNS) Lyme disease, not peripheral nervous system (PNS) disorders. CSF CXCL13 may provide useful adjunctive information in CNS infection; its specificity remains to be defined. Lyme encephalopathy is not indicative of CNS infection. Post treatment Lyme disease symptoms do not occur in patients who have had definite CNS Lyme infection. Whether post treatment Lyme disease symptom (PTLDS) is an actual entity, or reflects anchoring bias when commonly occurring symptoms arise in patients previously treated for Lyme disease, remains to be determined. Regardless, these symptoms do not reflect CNS infection and do not respond to additional antimicrobial therapy. Summary Serologic testing is robust in individuals with a priori likelihood of infection of greater than 2-6 weeks duration. Western blots provide useful confirmation of screening ELISAs, but may be replaced by second ELISAs. CSF testing, including CXCL13, may be informative in CNS Lyme, not PNS, and is generally normal in Lyme encephalopathy. PTLDS does not occur following CNS infection, and may not be a distinct entity.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [41] Rare manifestations of lyme neuroborreliosis
    Sergeev, A.
    Skoromets, A.
    Sergeeva, A.
    Barantsevich, E.
    Matyushkin, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [42] Lyme Neuroborreliosis in 2 Horses
    Imai, D. M.
    Barr, B. C.
    Daft, B.
    Bertone, J. J.
    Feng, S.
    Hodzic, E.
    Johnston, J. M.
    Olsen, K. J.
    Barthold, S. W.
    VETERINARY PATHOLOGY, 2011, 48 (06) : 1151 - 1157
  • [43] Unilateral mydriasis in Lyme neuroborreliosis
    Felten, R.
    Benoilid, A.
    Do Rego, C. Alves
    Collongues, N.
    De Seze, J.
    REVUE NEUROLOGIQUE, 2015, 171 (05) : 451 - 452
  • [44] Lyme neuroborreliosis in Great Britain
    Tweedie, A.
    LANCET NEUROLOGY, 2008, 7 (01): : 25 - 25
  • [45] Diagnosis and management of Lyme neuroborreliosis
    Halperin, John J.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (01) : 5 - 11
  • [46] Sublime diagnosis of Lyme neuroborreliosis
    Segal, BM
    Logigian, EL
    NEUROLOGY, 2005, 65 (03) : 351 - 352
  • [47] Cerebrovascular diseases in Lyme neuroborreliosis
    Richard, S.
    Wittwer, B.
    Pelletier, S.
    Lavandier, K.
    Lacour, J. -C.
    Mione, G.
    Maillard, L.
    Ducrocq, X.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 730 - 730
  • [48] The rhesus model of Lyme neuroborreliosis
    Pachner, AR
    IMMUNOLOGICAL REVIEWS, 2001, 183 : 186 - 204
  • [49] A Twist on Lyme: the Challenge of Diagnosing European Lyme Neuroborreliosis
    Makhani, Naila
    Morris, Shaun K.
    Page, Andrea V.
    Brophy, Jason
    Lindsay, L. Robbin
    Banwell, Brenda L.
    Richardson, Susan E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) : 455 - 457
  • [50] Paediatric Lyme Neuroborreliosis: a case report
    Ottavi, G.
    Ferroni, S.
    Capuano, E.
    Giuliani, S.
    Ramelli, G. P.
    SWISS MEDICAL WEEKLY, 2016, 146 : 36S - 36S